A new strategy to strengthen the body’s natural immune defenses against cancer is showing early promise, particularly for patients with limited treatment options.

Artiva Biotherapeutics (ARTV) is maintained as a "Buy," driven by FDA alignment for a single phase 3 trial of AlloNK plus ...

Scientists have developed a strategy to boost the cancer-fighting power of natural killer (NK) cells, part of the immune ...

Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it ...

Founder Patrick Soon-Shiong said the company’s AI-powered immune cell manufacturing robot is already in production. ・The “world’s first” NK-cell manufacturing robot uses AI and machine learning to ...

French biotech Innate Pharma is recruiting natural-born killers to target B cell non-Hodgkin lymphoma (B-NHL). The company’s tetraspecific antibody controlled tumors and improved survival in mice and ...

ImmunityBio will deliver what it calls the world’s first AI-powered NK-cell manufacturing robot this month, aiming to automate production of cancer-killing immune cells. Founder Patrick Soon-Shiong ...

Allogeneic, or “off-the-shelf,” cell therapies promise something different: one donor’s cells banked and shipped on demand to ...

Natural killer cells, also referred to as NK cells, play several major roles in the body's defense against cancers like renal cell carcinoma. Natural killer cells, also referred to as NK cells, play ...

Researchers suppressed two inhibitory proteins using small-molecule drugs. The approach enhanced natural killer cell killing ...